The Improvement Of Pelvic Exams for Patients With Chronic Vulvovaginal Conditions

July 27, 2018 updated by: Rebecca Rinko, Drexel University
The purpose of this study is to investigate patients self-reported comfort levels during each section of the pelvic exam.

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of this randomized controlled trial is to investigate the sequence in which physicians perform the pelvic exam, describe and compare self-reported comfort during each section of the pelvic exam and how comfort during the examinations related to quality of life, self-esteem, and sexual function in English speaking females at least 18 years of age with chronic vulvovaginal conditions.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19102
        • Drexel Ob/Gyn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • English Speaking Are able to read and write English Are utilizing outpatient services and being seen for a first appointment at an outpatient Vulvodynia Center

Exclusion Criteria:

  • Non English Speaking
  • Patients who cannot read or write
  • Those who are pregnant
  • Those who do not have a chronic vulvovaginal condition
  • Patients other than "new" patients
  • Patients who would not otherwise need a speculum exam

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Observational
Normal pelvic exam exposures: External exam followed by speculum exam, followed by bimanual exam
Active Comparator: Experimental Pelvic Exam
Changing the order of the pelvic exam Intervention: External exam, bimanual exam,speculum exam
The pelvic exam will be completed in the following order: external, speculum, bimanual exam in the "standard" group. In the Experimental group the pelvic exam will be done with external xam, bimanual exam then speculum exam.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Score: A change of 13mm
Time Frame: Within 1 hour of the exam
ale from 0-10, measured in mm. A change from baseline of 13mm is considered a significant change
Within 1 hour of the exam

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Female Sexual Function Index-19
Time Frame: Within 1 hour of the exam
Score of less than 26.55 indicates sexual dysfunction
Within 1 hour of the exam
Wellbeing quality of life score: Range 0-4
Time Frame: Within 1 hour of the exam
High wellbeing 2.504.0, Low Wellbeing 1.5-2.4, and very low wellbeing 0-1.4
Within 1 hour of the exam
Rosenberg Self-esteem Score: Scale 10-40
Time Frame: Within 1 hour of the exam
Higher numbers indicate higher self-esteem
Within 1 hour of the exam

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2018

Primary Completion (Actual)

July 16, 2018

Study Completion (Actual)

July 16, 2018

Study Registration Dates

First Submitted

January 3, 2018

First Submitted That Met QC Criteria

January 3, 2018

First Posted (Actual)

January 9, 2018

Study Record Updates

Last Update Posted (Actual)

July 30, 2018

Last Update Submitted That Met QC Criteria

July 27, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • DrexelU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Experimental Pelvic Exam

Subscribe